Examining movement control in Parkinson's disease
Official title: Behavioural Study of Reaching Control in Healthy Volunteers and Volunteers With Parkinson Disease in Dynamical Context
Run by Université Catholique de Louvain · NCT05908266 · Data updated 2026-11-12
This study looks at how people with Parkinson's disease control their movements and whether they can adjust them while moving, to better understand the challenges they face with slow movements.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Université Catholique de Louvain Academic / other |
| Locations | 1 site (Louvain-la-Neuve) |
| Status | Recruiting |
| Started | May 1, 2023 |
| Main results expected | October 31, 2027 |
| Study ends | October 31, 2027 |
| Registry record updated | June 18, 2023 |
| Trial ID | NCT05908266 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with Parkinson's disease who can perform the required reaching tasks.
✕Probably not a fit
Patients who are unable to perform the task due to severe motor or cognitive impairments will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates how individuals with Parkinson's disease (PD) plan and adapt their movements, particularly focusing on the role of the basal ganglia in evaluating movement costs. The researchers aim to determine whether patients with PD can update their movement control during ongoing actions, which may reveal insights into the mechanisms behind bradykinesia. By assessing reaching movements, the study seeks to clarify the relationship between movement planning and the integrity of the basal ganglia in PD patients.
Why it matters
Potential benefit: If successful, this study could enhance our understanding of movement disorders in Parkinson's disease and lead to improved therapeutic strategies.
How similar studies have gone: While the specific approach of this study may be novel, previous research has indicated the importance of the basal ganglia in movement control, suggesting potential for meaningful insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ability to perform the task (assessed during the experiment) Exclusion Criteria: * Inability to perform the task (motor) or to understand the task requirements (cognitive)
Where it's running
-
Université catholique de Louvain
Louvain-la-Neuve, Belgium Recruiting
Study contacts
- Study coordinator: André Mouraux, PhD
- Email: andre.mouraux@uclouvain.be
- Phone: +32 2 764 54 47
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.